Zur Rose Group AG announced that the Board of Directors is appointing Walter Hess to succeed Walter Oberh-nsli as CEO after the General Meeting. He will assume the position after the General Meeting. Walter Hess has spent a year as Head Germany and CEO of DocMorris. Before switching to Germany he spent six years as Head Switzerland, and prior to that two years as managing director of German subsidiary Zur Rose Pharma GmbH, Halle (Saale). He had worked for the Zur Rose Group in Germany as an external advisor since 2008. His successor will be announced at a later date.